These benefits, along with a previous report showing that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,two support the strategy of targeting ACKR3 as a novel way to modulate the opioid method, which could open up new therapeutic avenues for opioid-associated disorders. (two) The doctor has received https://janev739nev5.bimmwiki.com/user